Company / Tangible Book Value per Share
RECURSION PHARMACEUTICALS, INC. Tangible Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.44
FY2025
5-year range
-$1.22 / $24.30
FY2021-FY2025
Trend
-35.4%
vs FY2024
Sector context
#135 of 209
Health Care
What the data says
At $2.44, RECURSION PHARMACEUTICALS, INC.'s tangible book value per share ranks #135 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 7 years, ranging from $-9.51 in FY2020 to $24.30 in FY2021.
Based on SEC 10-K filings.
2.44 in FY2025.
Improved from $2.15 to $2.44 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#135 of 209 in Health CareTop 65% of 209This company $2.44 Sector average $119.74
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 35.4% year-over-year.
- Ranks #135 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.44 | -35.4% |
| FY2024 | $3.78 | +75.6% |
| FY2023 | $2.15 | +277.1% |
| FY2022 | -$1.22 | -105.0% |
| FY2021 | $24.30 | +355.5% |
| FY2020 | -$9.51 | -65.0% |
| FY2019 | -$5.76 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026